Podcasts about thoracic surgery

What were the most practice-changing thoracic surgery papers of 2024? In this episode of Thinking Thoracic, Dr. Linda Martin, UVA Health, and Dr. Jeff Yang, Thinking Thoracic co-host, spotlight top studies shaping the field, from groundbreaking lung cancer and esophageal cancer findings to surgical profession papers that impact how surgeons work and lead. Dr. Martin's curated list is a go-to resource for surgeons looking to stay at the forefront of evidence-based care. Check out her GTSC Key Papers presentation here. 

Dr. John Lazar, Chief of Thoracic Surgery and Oncology at Ascension Saint Thomas in Nashville speaks about lung cancer, treatments, causes, and risk factors. The lung cancer rate is higher in Tennesee and other Southeastern states because the smoking rate is higher. He discusses an unexpected rise of lung cancers in women of a particular demographic with NO obvious risk factors who are, nevertheless, developing the cancers. He also tells Anna the latest developments in detecting lung cancers, both in blood testing and imaging.See omnystudio.com/listener for privacy information.

Welcome back to our series on AI for the clinician! Large language models, like ChatGPT, have been taking the world by storm, and healthcare is no exception to that rule – your institution may already be using them! In this episode we'll tackle the fundamentals of how they work and their applications and limitations to keep you up to date on this fast-moving, exciting technology. Hosts: Ayman Ali, MD Ayman Ali is a Behind the Knife fellow and general surgery PGY-3 at Duke Hospital in his academic development time where he focuses on data science, artificial intelligence, and surgery. Ruchi Thanawala, MD: @Ruchi_TJ Ruchi Thanawala is an Assistant Professor of Informatics and Thoracic Surgery at Oregon Health and Science University (OHSU) and founder of Firefly, an AI-driven platform that is built for competency-based medical education. In addition, she directs the Surgical Data and Decision Sciences Lab for the Department of Surgery at OHSU.  Phillip Jenkins, MD: @PhilJenkinsMD Phil Jenkins is a general surgery PGY-3 at Oregon Health and Science University and a National Library of Medicine Post-Doctoral fellow pursuing a master's in clinical informatics. Steven Bedrick, PhD: @stevenbedrick Steven Bedrick is a machine learning researcher and an Associate Professor in Oregon Health and Science University's Department of Medical Informatics and Clinical Epidemiology. Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

Welcome to our new series – the AI Journal Club! In this series, we'll cover some interesting studies and evidence-based applications of artificial intelligence in surgery in a case-based format. Surely AI can find a DVT by now … or can it? Stay tuned and find out! Hosts: - Ayman Ali, MD Ayman Ali is a Behind the Knife fellow and general surgery PGY-3 at Duke Hospital in his academic development time where he focuses on data science, artificial intelligence, and surgery. - Ruchi Thanawala, MD: @Ruchi_TJ Ruchi Thanawala is an Assistant Professor of Informatics and Thoracic Surgery at Oregon Health and Science University (OHSU) and founder of Firefly, an AI-driven platform that is built for competency-based medical education. In addition, she directs the Surgical Data and Decision Sciences Lab for the Department of Surgery at OHSU.  - Marisa Sewell, MD: @MarisaSewell Marisa Sewell is a general surgery PGY-4 at Oregon Health and Science University.  Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

In this episode, Dr Bleri CELMETA takes us on a powerful journey through the history of open-heart surgery — from the pioneering work of John Gibbon and C. Walton Lillehei to the evolution of minimally invasive and robotic approaches. Discover how cardiac surgery progressed from experimental beginnings to life-saving daily procedures, and how innovation continues to shape the operating room. Dr. Bleri Celmeta is a cardiac surgeon operating on the Minimally Invasive Cardiac Surgery Unit in Galeazzi-Sant'Ambrogio Hospital (Milan, Italy). He graduated in Medicine and Surgery at the University of Padova-Italy in 2014, then completed his residency program in Cardiac Surgery in the same university in 2020. His professional background included also a fellowship in Cardiac and Thoracic Surgery in the University Hospital of Nantes-France (2019-2020).   He is the author of numerous publications and conference presentations with particular interest in minimally invasive cardiac surgery, and review editor of various international Journals (Frontiers in Cardiovascular Medicine, Frontiers in Surgery, Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery, Journal of Cardiothoracic Surgery, among others). Dr. Celmeta is a member of the Working Group on Cardiovascular Surgery - European Society of Cardiology (ESC), Italian Cardiac Surgery Society (SICCH) and Italian Society of Echocardiography and Cardiovascular Imaging (SIECVI).  LinkedIn profile: Bleri Celmeta | LinkedIn     About Behind the OR Behind the OR is the official podcast channel by Peters Surgical. Here, we invite you to step into the world of surgery, where we uncover what happens behind the closed doors of the operating room and beyond. Each episode features in-depth conversations with expert surgeons, providing insights into the latest surgical techniques, innovations, and the daily lives of those who dedicate themselves to saving lives. Founded in 1926, Peters Surgical is a French company with a global presence in over 90 countries. As a reference group for surgical practices worldwide, we are dedicated to improving surgical outcomes through innovative medical devices, including surgical sutures, hemostatic clips, and surgical glue. Our expertise lies in designing, manufacturing, and distributing these devices.  Visit our website here : https://peters-surgical.com/

Listen as we discuss the highly-awaited ESOPEC trial, which examines treatment regimens for esophageal and EGJ adenocarcinoma. Wildly impress your thoracic attendings or peers with your nuanced knowledge! FLOT who? You'll know. Pull out the paper and listen along! Learning Objectives: -Discuss the patient population in the ESOPEC trial -Discuss the main differences between the ESOPEC trial and the CROSS trial -Describe the main drawbacks between FLOT and the CROSS regimen. Hosts: Chloe Hanson MD, Brian Louie MD, and Peter White MD   Referenced Material https://www.nejm.org/doi/full/10.1056/NEJMoa2409408 Hoeppner J, Brunner T, Schmoor C, Bronsert P, Kulemann B, Claus R, Utzolino S, Izbicki JR, Gockel I, Gerdes B, Ghadimi M, Reichert B, Lock JF, Bruns C, Reitsamer E, Schmeding M, Benedix F, Keck T, Folprecht G, Thuss-Patience P, Neumann UP, Pascher A, Imhof D, Daum S, Strieder T, Krautz C, Zimmermann S, Werner J, Mahlberg R, Illerhaus G, Grimminger P, Lordick F. Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer. N Engl J Med. 2025 Jan 23;392(4):323-335. doi: 10.1056/NEJMoa2409408. PMID: 39842010. https://www.nejm.org/doi/full/10.1056/NEJMoa1112088 van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, Richel DJ, Nieuwenhuijzen GA, Hospers GA, Bonenkamp JJ, Cuesta MA, Blaisse RJ, Busch OR, ten Kate FJ, Creemers GJ, Punt CJ, Plukker JT, Verheul HM, Spillenaar Bilgen EJ, van Dekken H, van der Sangen MJ, Rozema T, Biermann K, Beukema JC, Piet AH, van Rij CM, Reinders JG, Tilanus HW, van der Gaast A; CROSS Group. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012 May 31;366(22):2074-84. doi: 10.1056/NEJMoa1112088. PMID: 22646630. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)32557-1/abstract Al-Batran SE, Homann N, Pauligk C, Goetze TO, Meiler J, Kasper S, Kopp HG, Mayer F, Haag GM, Luley K, Lindig U, Schmiegel W, Pohl M, Stoehlmacher J, Folprecht G, Probst S, Prasnikar N, Fischbach W, Mahlberg R, Trojan J, Koenigsmann M, Martens UM, Thuss-Patience P, Egger M, Block A, Heinemann V, Illerhaus G, Moehler M, Schenk M, Kullmann F, Behringer DM, Heike M, Pink D, Teschendorf C, Löhr C, Bernhard H, Schuch G, Rethwisch V, von Weikersthal LF, Hartmann JT, Kneba M, Daum S, Schulmann K, Weniger J, Belle S, Gaiser T, Oduncu FS, Güntner M, Hozaeel W, Reichart A, Jäger E, Kraus T, Mönig S, Bechstein WO, Schuler M, Schmalenberg H, Hofheinz RD; FLOT4-AIO Investigators. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. Lancet. 2019 May 11;393(10184):1948-1957. doi: 10.1016/S0140-6736(18)32557-1. Epub 2019 Apr 11. PMID: 30982686. ***Fellowship Application Link: https://forms.gle/PQgAvGjHrYUqAqTJ9 Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more. If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

Welcome to the Sterile Technique Podcast! It's the podcast about Surgical Technology. Whether you are a CST or CSFA, this podcast helps you earn CE credits and improve your surgery skills in the OR. This episode discusses an article in the March 2025 issue of The Surgical Technologist, the official journal of the Association of Surgical Technologists (AST). The article is titled, "Robot-Assisted Thoracic Surgery in Non-Small Cell Lung Cancer". "Scrub in" at steriletpodcast.com and on Twitter, @SterileTPodcast (twitter.com/SterileTPodcast). This podcast is a Dybas Media production. Sound effects adapted from GarageBand and sindhu.tms at https://freesound.org/people/sindhu.tms/sounds/169065/ and licensed courtesy of https://creativecommons.org/licenses/by-nc/3.0/.

We welcome Dr. Byron Patton, Regional Chief of Thoracic Surgery at Nuvance Health. Sarah LaDuke hosts.

As part of IASLC's ongoing series of podcasts in world languages, Dr. Balazs Halmos moderates a discussion in Hungarian with Dr. Krisztina Bogos, Dr. Ferenc Rényi-Vámos and Dr. Zsolt Megyesfalvi. The podcast reviews recent advances in lung cancer screening, diagnosis and management with a particular focus on implementation in Hungary. Highlights of the discussion include novel staging and diagnostic tools, state-of-the-art biomarker testing, perioperative therapy and clinical trials access. Host: Balazs Halmos, MD, Director, Thoracic Oncology & Clinical Cancer Genomics, Montefiore Medical Park at Eastchester, Bronx, New York Guest: Ferenc Rényi-Vámos, MD, PhD, Thoracic Surgery, Semmelweis University and National Institute of Oncology, Budapest, Hungary Guest: Krisztina Bogos, MD, Thoracic Oncology National Koranyi Institute of Pulmonology, Budapest, Hungary Lung Cancer Research and Pathology Guest: Zsolt Megyesfalvi, MD, PhD, Semmelweis University and National Institute of Oncology, Budapest, Hungary and National Koranyi Institute of Pulmonology, Budapest, Hungary

In this episode of Compassion and Courage, Marcus speaks with Ryan Sheridan, a physician assistant specializing in cardiothoracic surgery. They discuss Ryan's journey into the medical field, the importance of compassionate communication in healthcare, and the flexibility of a PA's role. Ryan shares insights on how to practice compassion with patients, especially in post-operative care, and the significance of honesty when communicating both good and bad outcomes. Come listen to Ryan's experience with leadership skills, the importance of being present with patients, and personal stories that highlight the power of compassion in healthcare and just trying. Key Moments00:00 – Introductions00:45 – Ryan's Journey to Becoming a PA05:05 – Practicing Compassion in Post-Operative Care08:00 – Communicating Good and Bad Outcomes14:30 – The Impact of Compassion on Patient Care20:50 – Lessons in Leadership from Family23:50 – A Personal Story of Compassion29:40 – Getting to Know Ryan. "Enjoy It."34:15 – Conclusion and Thank Yous Resources for you: More communication tips and resources for how to cultivate compassion: https://marcusengel.com/freeresources/Connect with Marcus on LinkedIn: https://www.linkedin.com/in/marcusengel/Learn more about Marcus' Books: https://marcusengel.com/store/Subscribe to our podcast through Apple: https://bit.ly/MarcusEngelPodcastSubscribe to our podcast through YouTube: https://bit.ly/Youtube-MarcusEngelPodcast More about Ryan:Ryan Sheridan, Physician Assistant practicing Thoracic Surgery in New York. Date: 3/10/2025 Name of show: Compassion & Courage: Conversations in Healthcare Episode number and title: Episode 163 – The Heart of Compassionate Care – Ryan Sheridan, Thoracic Surgery PA

A pediatric thoracic surgeon at Indiana University, has spent decades fixing broken hearts. And his research led him to a team of engineers at NASA.

Dr. Daniel Hale Williams is often described as the first person to successfully perform an open-heart surgery. That's not entirely accurate, but he was still a surgical innovator, and he was also a huge part of the Black Hospital Movement. Research: "Daniel Hale Williams." Contemporary Black Biography, vol. 2, Gale, 1992. Gale In Context: U.S. History, link.gale.com/apps/doc/K1606000260/GPS?u=mlin_n_melpub&sid=bookmark-GPS&xid=c4ae7664. Accessed 28 Jan. 2025. "Daniel Hale Williams." Notable Black American Men, Book II, edited by Jessie Carney Smith, Gale, 1998. Gale In Context: U.S. History, link.gale.com/apps/doc/K1622000479/GPS?u=mlin_n_melpub&sid=bookmark-GPS&xid=80e75e7e. Accessed 28 Jan. 2025. Buckler, Helen. “Doctor Dan: Pioneer in American Surgery.” Little, Brown and Company. 1954. Cobb, W M. “Daniel Hale Williams-Pioneer and Innovator.” Journal of the National Medical Association vol. 36,5 (1944): 158-9. COBB, W M. “Dr. Daniel Hale Williams.” Journal of the National Medical Association vol. 45,5 (1953): 379-85. Cook County Health. “Celebrating 30 Years: Provident Hospital of Cook County.” https://cookcountyhealth.org/provident-hospital-30th-anniversary/ Gamble, Vanessa Northington. “Making a place for ourselves : the Black hospital movement, 1920-1945.” New York : Oxford University Press. 1995. Gamble, Vanessa Northington. “The Provident Hospital Project: An Experiment in Race Relations and Medical Education.” Bulletin of the History of Medicine, WINTER 1991. Via JSTOR. https://www.jstor.org/stable/44442639 Gordon, Ralph C. “Daniel Hale Williams: Pioneer Black Surgeon and Educator.” Journal of Investigative Surgery, 18:105–106, 2005. DOI: 10.1080/08941930590956084 Hughes, Langston. “Famous American Negroes.” Dodd Mead. 1954. Jackson State University. “Who Was Dr. Daniel Hale Williams?” https://www.jsums.edu/gtec/dr-daniel-hale-williams/ Jefferson, Alisha J. and Tamra S. McKenzie. “Daniel Hale Williams, MD: ‘A Moses in the profession.’” American College of Surgeons CC2017 Poster Competition. 2017. Office of the Illinois Secretary of State. “51. Dr. Daniel Hale Williams Letter to Governor Joseph Fifer (1889).” 100 Most Valuable Documents at the Illinois State Archives. https://www.ilsos.gov/departments/archives/online_exhibits/100_documents/1889-williams-letter-gov.html Olivier, Albert F. “In Proper Perspective: Daniel Hale Williams, M.D.” Annals of Thoracic Surgery. Volume 37, Issue 1p96-97 January 1984. https://www.annalsthoracicsurgery.org/article/S0003-4975(10)60721-7/fulltext Raman, Jai. “Access to the Heart – Evolution of surgical techniques.” Global Surgery. Vol. 1, No. 2. doi: 10.15761/GOS.1000112 Rock County, Wisconsin. “Dr. Daniel Hale Williams.” https://legacy.co.rock.wi.us/daniel-hale-williams Summerville, James. “Educating Black doctors : a history of Meharry Medical College.” University of Alabama Press. https://archive.org/details/educatingblackdo0000summ/ The Provident Foundation. “History- Dr. Daniel Hale Williams.” https://provfound.org/index.php/history/history-dr-daniel-hale-williams “Early Chicago: Hospital of Hope.” DuSable to Obama: Chicago’s Black Metropolis. https://www.wttw.com/dusable-to-obama/provident-hospital See omnystudio.com/listener for privacy information.

Description: As part of IASLC's commitment to communicating in all world languages, this episode of Lung Cancer Considered is recorded in German and is part of our Virtual Tumor Board series. Host Professor Alessandra Curioni-Fontecedro moderates a discussion with two colleagues, who will discuss the dynamic topic of managing resectable stage III NSCLC. Host: Prof Alessandra Curioni-Fontecedro, MD, Head of Oncology, Cantonal Hospital Fribourg, Chair of Medical Oncology, University of Fribourg Guest: Prof. Isabelle Opitz, Professor of Thoracic Surgery and Director of the Department of Thoracic Surgery at University Hospital of Zurich, Chair of the Lung Cancer Center of Zurich, and the past President of the European Society of Thoracic Surgery. She received the IASLC Robert J Ginsberg Lectureship Award for Surgery at the 2022 World Conference on Lung Cancer Guest: Prof. Michael Thomas, Chefarzt of Dept of Thoracic Oncology at the Thoraxklinik Heidelberg, Germany.

In this episode, Dr. Hari Keshava talks with Dr. Sid Murthy, section head, thoracic surgery at Cleveland Clinic, about thoracic surgical emergencies related to pulmonary and lung surgeries...and how optimal management of these situations often requires surgeons to anticipate, collaborate and be prepared with a well-thought-out action plan. 

Your post op day #4 right pneumonectomy patient is suddenly coughing up large volumes of serosanguinous sputum! What are you worried about and what do you need to do? Join your Swedish thoracic surgery team, Drs. Chloe Hanson, Peter White, and Brian Louie as we discuss the management of this dangerous and frustrating surgical complication. Hosts: Chloe E. Hanson, M.D., PGY3 Brian E. Louie, MD, Thoracic Attending Peter T. White, MD, Thoracic Attending Learning Objectives: What is a bronchopleural fistula (BPF) and what different ways do they present? Describe the acute management of an early BPF. Describe the differences in operative considerations between an early and late BPF. Describe different options for closure of a pneumonectomy space. References: -  Sugarbaker's Adult Chest Surgery, 3e Sugarbaker DJ, Bueno R, Burt BM, Groth SS, Loor G, Wolf AS, Williams M, Adams A. Sugarbaker D.J., & Bueno R, & Burt B.M., & Groth S.S., & Loor G, & Wolf A.S., & Williams M, & Adams A(Eds.),Eds. David J. Sugarbaker, et al. https://shc.amegroups.org/article/view/3787/html -  Dal Agnol G, Vieira A, Oliveira R, Ugalde Figueroa PA. Surgical approaches for bronchopleural fistula. Shanghai Chest 2017;1:14. Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

In this episode of Lung Cancer Considered, host Dr. Stephen Liu and guests preview the publication of the Ninth Edition of Tumor, Node and Metastasis (TNM) Classification System for lung cancer. The new edition will be published in January 2025 and has some important changes that reflect an evolving understanding of the disease and more rigorous analysis of data from around the world. Guest: Dr. Valerie Rusch is a Thoracic Surgeon from Memorial Sloan Kettering Cancer CenterMSKCC where she is Vice Chair for Clinical Research in the Department of Surgery and the Miner Family Chair in Intrathoracic Cancers. She has held many leadership positions in the American College of Surgeons and other organizations and was part of the team to first described EGFR mutations. She has been chair of the Thoracic Committee for the American Joint Committee on Cancer 6th, 7th, 8th, and now 9th Editions of the Cancer Staging Handbook Guest: Dr. Hisao Asamura is a Professor of Surgery, Chief of Division of Thoracic Surgery at Keio University School of Medicine in Tokyo, Japan and Vice President of the Japan Lung Cancer Society. For IASLC, he is the Chair of the Staging and Prognostic Factors Committee, former Executive Board Director, and Congress President for the 18th World Conference on Lung Cancer. Guest: Dr. Enrico Ruffini is a Thoracic Surgeon and Professor of Thoracic Surgery from the University of Torino, Italy where he is the Chief of the Thoracic Surgery Unit and Director of the Thoracic Surgery Residency Program. He is heavily involved in the European Society of Thoracic Surgeons and Chair of the IASLC Staging and Prognostic Factors Committee – Thymic domain.

Dr. Ankit Bharat, Chief of Thoracic Surgery and Director of the Canning Thoracic Institute at Northwestern Medicine, joins Lisa Dent on the show to share details surrounding a study that shows there is a connection between COVID-19 and cancer regression.

Many significant medical discoveries were accidents, such as Fleming's discovery of penicillin in 1929. Similarly, in 1958, Dr. Mason Sones from the Cleveland Clinic accidentally injected contrast into a patient's right coronary artery, leading to a cardiac arrest. However, this incident allowed the first detailed visualization of the coronary artery, eventually leading to the development of coronary angiography, which remains the gold standard today. Dr Bleri CELMETA highlight these advancements, and explains the evolutions from open procedures to minimally invasive and robotic techniques.   Dr. Bleri Celmeta is a cardiac surgeon operating on the Minimally Invasive Cardiac Surgery Unit in Galeazzi-Sant'Ambrogio Hospital (Milan, Italy). He graduated in Medicine and Surgery at the University of Padova-Italy in 2014, then completed his residency program in Cardiac Surgery in the same university in 2020. His professional background included also a fellowship in Cardiac and Thoracic Surgery in the University Hospital of Nantes-France (2019-2020).   He is the author of numerous publications and conference presentations with particular interest in minimally invasive cardiac surgery, and review editor of various international Journals (Frontiers in Cardiovascular Medicine, Frontiers in Surgery, Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery, Journal of Cardiothoracic Surgery, among others). Dr. Celmeta is a member of the Working Group on Cardiovascular Surgery - European Society of Cardiology (ESC), Italian Cardiac Surgery Society (SICCH) and Italian Society of Echocardiography and Cardiovascular Imaging (SIECVI).  LinkedIn profile: Bleri Celmeta | LinkedIn     About Behind the OR Behind the OR is the official podcast channel by Peters Surgical. Here, we invite you to step into the world of surgery, where we uncover what happens behind the closed doors of the operating room and beyond. Each episode features in-depth conversations with expert surgeons, providing insights into the latest surgical techniques, innovations, and the daily lives of those who dedicate themselves to saving lives. Founded in 1926, Peters Surgical is a French company with a global presence in over 90 countries. As a reference group for surgical practices worldwide, we are dedicated to improving surgical outcomes through innovative medical devices, including surgical sutures, hemostatic clips, and surgical glue. Our expertise lies in designing, manufacturing, and distributing these devices.  Visit our website here : https://peters-surgical.com/

Send us a textLung cancer is the leading cause of cancer deaths in both men and women, resulting in more cancer deaths than breast, prostate, and colorectal cancers combined. It can take years to develop and is difficult to detect in early stages when there is greater potential for a cure. Fortunately, lung cancer survival rates are improving, thanks to advances in screening and treatment options, including breakthrough therapies that we're leading at MedStar Health. In partnership with the Georgetown Lombardi Comprehensive Cancer Center—a National Cancer Institute-designated comprehensive cancer center—we can offer our patients promising clinical trials years before they become the standard of care. Dr. Edward Chan is the Chief of Thoracic Surgery at MedStar Washington Hospital Center. Dr. Chan sees patients at MedStar Washington Hospital Center and MedStar Georgetown University Hospital. Dr. Chan is double-board certified and specializes in general thoracic surgery. He treats patients for lung cancer, esophageal cancer, benign esophageal diseases (such as acid reflux/hiatal hernia and achalasia), and mediastinal tumors. For an interview with Dr. Edward Chan, or for more information about this podcast, contact MedStar Georgetown University Hospital Manager Media Relations, Ryan.M.Miller2@Medstar.net.  Learn more about Dr. Chan. For more episodes of MedStar Health DocTalk, go to medstarhealth.org/doctalk.

Title: IASLC Hot Topic Meeting on Tolerance and Resistance to Targeted Therapy in NSCLC (recorded on 10/21) Description: In this episode of Lung Cancer Considered, host Dr. Stephen Liu previews the upcoming IASLC Hot Topic Meeting on Tolerance and Resistance to Targeted Therapy in NSCLC. To discuss this exciting new meeting and this topic, he is joined by the four co-chairs of the meeting. To learn more about the meeting, visit https://www.httr2024-iaslc.org/. Guest: Dr. Alice Berger is an Associate Professor in the Human Biology Division and the Herbold Computational Biology Program at the Fred Hutchinson Cancer Center at the University of Washington in Seattle, Wash. X: @aliceb_phd Guest: Dr. Kenichi Suda, Associate Professor in the Division of Thoracic Surgery at Kindai University School of Medicine in Osaka, Japan. X: NA Guest: Dr. Montse Sanchez-Cespedes is the Group Leader at the Josep Carreras Research Institute, in Badalona, Spain X: @CespedesMontse Guest: Dr. William Lockwood, Senior Scientist in Integrative Oncology at the BC Cancer Research Institute and Associate Professor in Pathology & Laboratory Medicine at the University of British Columbia in Vancouver, Canada X: @WWL_18

A client had a complex surgical procedure on her heart two weeks prior, but it was conducted by way of a catheter threaded up her femoral artery and aorta. Now, she wants to receive massage again. A quick Google search suggests that it would be OK. Her MT is skeptical and wants to be more conservative. Who is right? Listen on for information about transcatheter aortic valve replacement (TAVR) surgery, using AI to make clinical decisions, and how to get to “yes” for people who have recently had surgery. Host Bio:                    Ruth Werner is a former massage therapist, a writer, and an NCBTMB-approved continuing education provider. She wrote A Massage Therapist's Guide to Pathology, now in its seventh edition, which is used in massage schools worldwide. Werner is also a long-time Massage & Bodywork columnist, most notably of the Pathology Perspectives column. Werner is also ABMP's partner on Pocket Pathology, a web-based app and quick reference program that puts key information for nearly 200 common pathologies at your fingertips. Werner's books are available at www.booksofdiscovery.com. And more information about her is available at www.ruthwerner.com.                    Resources:    Pocket Pathology: https://www.abmp.com/abmp-pocket-pathology-app   Braun, L.A. et al. (2012) ‘Massage therapy for cardiac surgery patients--a randomized trial', The Journal of Thoracic and Cardiovascular Surgery, 144(6), pp. 1453–1459, 1459.e1. Available at: https://doi.org/10.1016/j.jtcvs.2012.04.027.   Grafton-Clarke, C. et al. (2019) ‘Can postoperative massage therapy reduce pain and anxiety in cardiac surgery patients?', Interactive Cardiovascular and Thoracic Surgery, 28(5), pp. 716–721. Available at: https://doi.org/10.1093/icvts/ivy310.   Patients Who Stay in Hospital Less Than 3 Days After TAVR Fare Better (no date) American College of Cardiology. Available at: https://www.acc.org/about-acc/press-releases/2019/03/04/13/53/http%3a%2f%2fwww.acc.org%2fabout-acc%2fpress-releases%2f2019%2f03%2f04%2f13%2f53%2fpatients-who-stay-in-hospital-less-than-3-days-after-tavr-fare-better (Accessed: 26 September 2024).   Pressler, A. et al. (2018) ‘Long-term effect of exercise training in patients after transcatheter aortic valve implantation: Follow-up of the SPORT:TAVI randomised pilot study', European Journal of Preventive Cardiology, 25(8), pp. 794–801. Available at: https://doi.org/10.1177/2047487318765233.   Transcatheter Aortic Valve Replacement (TAVR) (no date). Available at: https://my.clevelandclinic.org/health/treatments/17570-transcatheter-aortic-valve-replacement-tavr (Accessed: 25 September 2024).   Wang, A.T. et al. (2010) ‘Massage therapy after cardiac surgery', Seminars in Thoracic and Cardiovascular Surgery, 22(3), pp. 225–229. Available at: https://doi.org/10.1053/j.semtcvs.2010.10.005.   What recovery looks like 6 months after an aortic valve replacement (2023). Available at: https://www.medicalnewstoday.com/articles/6-months-after-aortic-valve-replacements (Accessed: 25 September 2024).   Sponsors:   Anatomy Trains: www.anatomytrains.com    Elements Massage: www.elementsmassage.com/abmp   MassageBook: www.massagebook.com   Books of Discovery: www.booksofdiscovery.com   The American Massage Conference: www.massagetherapymedia.com/conferences    

In today's episode, supported by AstraZeneca, we had the pleasure of speaking with Sandip P. Patel, MD, and Brendon M. Stiles, MD, about the FDA approval of perioperative durvalumab (Imfinzi) for patients with resectable non–small cell lung cancer (NSCLC). Dr Patel is a professor of medicine in the Department of Medicine at the University of California, San Diego. Dr Stiles is a professor of cardiothoracic surgery and chief of the Divisions of Thoracic Surgery and Surgical Oncology in the Department of Cardiothoracic & Vascular Surgery, as well as the associate director of Surgical Oncology at the Montefiore Einstein Comprehensive Cancer Center in Bronx, New York. On August 15, 2024, the FDA approved durvalumab plus platinum-containing chemotherapy in the neoadjuvant setting, followed by durvalumab monotherapy in the adjuvant setting, for the treatment of adult patients with resectable NSCLC with no known EGFR mutations or ALK rearrangements. This regulatory decision was backed by findings from the phase 3 AEGEAN trial (NCT03800134), in which the median event-free survival was not reached (95% CI, 31.9 months-not estimable [NE]) in patients who received the durvalumab regimen vs 25.9 months (95% CI, 18.9-NE) in those who received placebo plus chemotherapy (stratified HR, 0.68; 95% CI, 0.53-0.88; P = .0039). In our exclusive interview, Drs Patel and Stiles discussed the significance of this approval, key efficacy and safety findings from AEGEAN, and how the clinical use of perioperative treatment regimens reinforces the importance of involving multidisciplinary teams in every step of a patient's treatment plan.

Dennis received his B.Sc. and M. D. Degrees from the University of Alberta, and his MSc. Degree and training in General Surgery, Cardiovascular and Thoracic Surgery and Critical Care at McGill University, he spent 3 more years of training in transplantation immunology, heart and lung transplantation and high-risk cardiovascular surgery at Stanford University Medical Center. He implemented Western Canada's first heart and lung transplantation program and served as the Director of both the Heart and Lung Transplantation Program and Cardiovascular Intensive Care Unit for 20+ years. He spent 30 years as a practising doctor and is the former CEO of the Alberta Prosperity Project. We discuss Alberta's position in Canada, the pace of government and the Alberta first mindset.  Clothing Link:⁠⁠⁠https://snp-8.creator-spring.com/listing/the-mashup-collection⁠⁠ Text Shaun 587-217-8500 Substack:https://open.substack.com/pub/shaunnewmanpodcast E-transfer here: shaunnewmanpodcast@gmail.com Silver Gold Bull Links: Website: https://silvergoldbull.ca/ Email: SNP@silvergoldbull.com Text Grahame: (587) 441-9100

Host Dr. Narjust Florez previews the 2024 Latin America Lung Cancer Meeting with co-chairs Dr. Lucia Viola, Dr. Andres Feliple Cardona and Dr. Stella Martinez. LALCA is a dynamic meeting with a long tradition that features the most up-to-date research, diverse topics of interest, and educational sessions with leading experts. Guest: Dr. Lucia Viola Interventional Pulmonologist- Head of Thoracic Oncology Service. She is a member of the Fundación Neumológica Colombiana - Fundación CTICGuest: Dr. Andrés Felipe Cardona is the Director of Research, Science and Education of the Luis Carlos Sarmiento Angulo Cancer Treatment and Research Center (CTIC) located in Bogotá, Colombia. Guest: Dr. Stella Martinez is an Associate Professor of thoracic Surgery and Director of the Specialization Program in Thoracic Surgery at El Bosque University in Bogotá, Colombia.

In this episode of High Velocity Careers, Stone Payton speaks with Dr. Daniel Fortes, Division Chief of Thoracic Surgery at Wellstar, and Will Chilvers, the Director of Outpatient Imaging Services at Northside Hospital. They discuss their unique career paths, the challenges they face in healthcare, and the importance of combining clinical expertise with business acumen. […]

Did you know that...- 1 IN 16 PEOPLE will be diagnosed with lung cancer in their lifetime- LUNG CANCER kills almost 3 times as many women as breast cancer- Approximately 127,070 AMERICAN LIVES are lost annually to lung cancer.And there's much more to be learned about lung cancer and how it's affecting women.This week Sybil is joined by Dr. Loretta Erhunmwunsee to discuss everything we need to know to protect ourselves from lung cancer + the environmental impacts that increase the rates of lung cancer diagnosis in black and brown communities more than others.Listen and learn:Who is most at risk for lung cancerWho should get screened for lung cancer and whyNon-smokers: how do you protect yourself from lung cancer?How insurance coverage affects screenings and treatmentsAND MORE!Special thanks to HealthyWomen in partnership with Daiichi Sankyo and Merck for introducing this topic to our audience.

Description: In this episode of Lung Cancer Considered, host (and WCLC 2024 Co-Chair) Dr. Narjust Florez previews the upcoming IASLC 2024 World Conference on Lung Cancer with the meeting's other three co-chairs. Guest: Dr. Linda Martin, Professor of Surgery and Chief of Thoracic Surgery at the University of Virginia. Guest: Dr. Fabio Ynoe de Moraes, Chief of Global Radiation Oncology and Associate Professor of Radiation Oncology at Queen University. Guest: Dr. Sandip Patel, Professor of Medicine and Thoracic Medical Oncologist at the University of California San Diego.

This week on Parallax, Dr Ankur Kalra welcomes Dr Marc Gerdisch to discuss a groundbreaking study on reducing opioid use after cardiac surgery. Dr Marc Gerdisch is the Chief of Cardiovascular and Thoracic Surgery and Co-Director of the Heart Valve Center and Atrial Fibrillation Program at Franciscan St. Francis Health. He is a senior partner at Cardiac Surgery Associates and a Clinical Assistant Professor of Thoracic and Cardiovascular Surgery at Loyola University Medical Center in Chicago. Dr Gerdisch shares insights into his research on rigid sternal fixation and enhanced recovery protocols, which have shown promising results in postoperative pain management and patient recovery. In this episode, Dr Kalra and Dr Gerdisch discuss the specifics of the study, including the four-cohort design and the steps taken to expedite opioid-free recovery. Dr Gerdisch also shares valuable advice on overcoming physician inertia and building a strong case for implementing such a programme, including cost-benefit analysis considerations. What motivated the study? How can a holistic approach to cardiac surgery recovery be implemented? What advice does Dr Gerdisch have for our listeners? Sources: Gerdisch MW, et al. Ann Thorax Surg 2024. Rigid Sternal Fixation and Enhanced Recovery for Opioid-Free Analgesia After Cardiac Surgery. DOI: 10.1016/j.athoracsur.2024.06.032 CE Cox. TCTMD 2024. Holistic Approach to Cardiac Surgery Can Sharply Cut Opioid Use. Available at: https://www.tctmd.com/news/holistic-approach-cardiac-surgery-can-sharply-cut-opioid-use. Accessed August 12, 2024.

Host:  Dr. Jennifer Hunter, Assistant Director for Family and Consumer Sciences Extension, University of Kentucky Guests: Dr. Timothy Mullett, Medical Director and Professor of Thoracic Surgery and Ms. Cheri Tolle, Deputy Director, UK Markey Cancer Center Affiliate Network (MCCAN) In this episode, we delve into the origins and growth of the UK Markey Cancer Center Affiliate Network (MCCAN), since its inception in 2006 with just three hospitals, MCCAN has expanded to include 19 hospitals across Kentucky. Discover how this network fosters high-quality cancer care, allowing patients to receive top-notch treatment close to home, and when necessary, facilitating seamless referrals to the Markey Cancer Center in Lexington. Explore the compelling reasons why the National Cancer Institute designation is a game-changer for the Markey Cancer Center and its affiliates, with insights into the comprehensive support offered to community hospitals, including professional education, quality assurance, and patient navigation services. This episode underscores the importance of collaboration between community hospitals and the Markey Cancer Center, ensuring that patients benefit from advanced research and specialized care. MCCAN is transforming cancer care in Kentucky, making a profound impact on patients and communities alike by bringing cutting-edge cancer care to many far-reaching spaces across Kentucky. Cancer Conversations on Talking FACS is a partnership project between Family and Consumer Sciences Extension and the Markey Cancer Center. For more information about MCCAN visit: Markey Cancer Center Affiliate Network Connect with the UK Markey Center Online Markey Cancer Center On Facebook @UKMarkey On Twitter @UKMarkey Connect with FCS Extension through any of the links below: Kentucky Extension Offices UK FCS Extension           Website           Facebook           Instagram           FCS Learning Channel

Does the adult thymus have a purpose and function? Are there any long-term health effects of thymectomy? Tune in to another Swedish Thoracic surgery journal review where we discuss the recent paper out of the NEJM which reports on the health consequences of thymus removal in adults. This paper has been widely picked up by the media and our patients frequently bring it into the office. Listen as we discuss the study population, methods, and potential applications of this paper. Learning Objectives: - Review the purpose and function of the thymus. - Discuss the population, methods, and results of this trial. - Discuss the application of this paper and how it may or may not impact clinical practice for thoracic surgeons.  Hosts: Chloe E. Hanson, MD, PGY-3 Kelly Daus MD, PGY-4 Peter White, MD, Thoracic Surgery Attending Brian Louie, MD, Thoracic Surgery Attending Reference Material: Kooshesh KA, Foy BH, Sykes DB, Gustafsson K, Scadden DT. Health Consequences of Thymus Removal in Adults. N Engl J Med. 2023;389(5):406-417. https://pubmed.ncbi.nlm.nih.gov/37530823/ Lin TM, Chang YS, Hou TY, et al. Risk of incident autoimmune diseases in patients with thymectomy. Ann Clin Transl Neurol. 2020;7(7):1072-1082. https://pubmed.ncbi.nlm.nih.gov/32478484/ Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

In this podcast, Dr Bleri CELMETA explore the history and evolution of cardiac surgery. The series covers early challenges, such as : The belief that Heart Surgery was impossible and fatal The invention of the heart-lung machine Significant milestones like Alexis Carrel's vascular techniques and the first successful heart surgery in 1896 The podcast highlights the advancements that made modern cardiac surgery possible, emphasizing the evolution of medical practices and technologies.  Dr. Bleri Celmeta is a cardiac surgeon operating on the Minimally Invasive Cardiac Surgery Unit in Galeazzi-Sant'Ambrogio Hospital (Milan, Italy). He graduated in Medicine and Surgery at the University of Padova-Italy in 2014, then completed his residency program in Cardiac Surgery in the same university in 2020. His professional background included also a fellowship in Cardiac and Thoracic Surgery in the University Hospital of Nantes-France (2019-2020).   He is the author of numerous publications and conference presentations with particular interest in minimally invasive cardiac surgery, and review editor of various international Journals (Frontiers in Cardiovascular Medicine, Frontiers in Surgery, Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery, Journal of Cardiothoracic Surgery, among others). Dr. Celmeta is a member of the Working Group on Cardiovascular Surgery - European Society of Cardiology (ESC), Italian Cardiac Surgery Society (SICCH) and Italian Society of Echocardiography and Cardiovascular Imaging (SIECVI).  LinkedIn profile: Bleri Celmeta | LinkedIn     About Behind the OR Behind the OR is the official podcast channel by Peters Surgical. Here, we invite you to step into the world of surgery, where we uncover what happens behind the closed doors of the operating room and beyond. Each episode features in-depth conversations with expert surgeons, providing insights into the latest surgical techniques, innovations, and the daily lives of those who dedicate themselves to saving lives. Founded in 1926, Peters Surgical is a French company with a global presence in over 90 countries. As a reference group for surgical practices worldwide, we are dedicated to improving surgical outcomes through innovative medical devices, including surgical sutures, hemostatic clips, and surgical glue. Our expertise lies in designing, manufacturing, and distributing these devices.  Visit our website here : https://peters-surgical.com/

Isabelle Opitz, MD, is the director of the Department of Thoracic Surgery at University Hospital Zurich, Switzerland, and an associate professor for thoracic surgery at the University of Zurich, as well as the chair of the Lung Cancer Center in Zurich. In this episode of Same Surgeon, Different Light, Dr. Opitz talks with Dr. Thomas Varghese about her international career path, spanning Germany, France, and Switzerland, where she now resides. She explains how career journeys in Europe differ from the US, especially for women, and how the healthcare system overseas is striving for greater diversity and inclusion in the workplace. 

In this episode, Dr. Thomas Varghese joins Dr. Yolonda Colson, chief of the Division of Thoracic Surgery at Massachusetts General Hospital and professor of surgery at Harvard Medical School, in an insightful conversation on the advancement of women into key leadership roles and why that is still lacking today in the cardiothoracic surgery specialty. Dr. Olson shares her origin story - "from farm to the CT surgery field" - as an accomplished surgeon and scientist. Her advice on becoming a consistently high performer? "Stay focused on your purpose and not just the result. And stay open to new opportunities." 

Melanie is a single mom with 2 kids & a Linchpin member. She was born & raised in Guyana & moved to the US when she was 11 years old. She has an amazing career as a Thoracic Surgery PA & stays very busy raising her 2 kids & getting them to their sports practices/games. This is her story.

In a new CTSNet podcast for residents and trainees, host Dr. Alice Copperwheat examines essential procedures and pressing topics for early career cardiothoracic surgeons. In her debut episode, Alice speaks with CTSNet Editor in Chief Professor Joel Dunning about the basics of thoracic surgery. They discuss patient positioning, thoracic incision location and technique, and opening and closing techniques. They also debate the increasing popularity of robotic thoracic surgery and the merits of different surgical techniques. The Atrium will air once a month, rotating between clinical and career-focused topics from across the cardiothoracic surgery subspecialties. Stay tuned next month for an episode on vein harvesting. Disclaimer The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.

Comprehensive, relevant and insightful conversations about health and medicine from the largest healthcare system in the Maryland D.C. region: this is MedStar Health DocTalk.In our latest podcast episode, host Debra Schindler talks with thoracic surgeon Dr. Duane Monteith and gastroenterologist Dr. Dana Sloan for a comprehensive look into esophageal cancer. They discuss everything from early symptoms and risk factors to advanced treatment options like minimally invasive surgery. This episode is packed with valuable insights that could make a significant difference in early detection and treatment. For more episodes of MedStar Health DocTalk, go to medstarhealth.org/doctalk.

The robotic-assisted biopsy platform Ion is a “game-changer” for patients with lung cancer, as it provides a quicker, less invasive surgical method for conducting a lung biopsy, according to Richard Lazzaro, MD. In a conversation with CancerNetwork, Lazzaro, the chief of Thoracic Surgery at the Southern Region of RWJBarnabas Health, spoke about his experience with adopting the Ion robotic bronchoscopy platform for the early detection of lung cancer at Monmouth Medical Center. He highlighted how the tool may enable practices to acquire tissue and perform disease staging with fewer complications, which may particularly benefit those who plan to undergo induction chemotherapy or immunotherapy. In terms of other potential advancements in the lung cancer surgery field, Lazzaro discussed how he anticipates the use of video-assisted thoracoscopic (VATS) surgery to evolve. Specifically, he mentioned the development of technologies such as augmented reality as tools that may help minimize the variability of surgical procedures. Regarding his practice, Lazzaro highlighted how a multidisciplinary thoracic tumor board—including medical oncologists, radiologists, pathologists, and pulmonary physicians, among others—has helped in producing long-term survival improvements. He emphasized collective discussions and shared decision-making as part of determining appropriate courses of care for his patients. When it comes to a multidisciplinary approach, Lazzaro stated that “you want to take care of patients” like they were part of “your family.” Overall, Lazzaro noted how the lung cancer treatment landscape has changed over time. He emphasized referring patients for CT scans as well as evaluations at nodule or thoracic oncology clinics as part of a multidisciplinary strategy. “The management of lung cancer is different than it was even 5 years ago. If we can detect lung cancer early, we have options for treating patients today that we never had before,” Lazzaro said. “This is the time where we really need to make a huge difference in lung cancer.” Reference Latest most advanced treatments for lung cancer now available at Monmouth Medical Center. News release. RWJBarnabas Health. January 22, 2024. Accessed April 17, 2024. https://tinyurl.com/ty8st3hm

In this episode our team dives into the diagnosis, workup and management of malignant pleural mesothelioma. Listen as we debate the pros and cons of surgical management of this disease with extrapleural pneumonectomy versus pleural decortication and discuss the nuances of choosing the right approach for the right patient. Learning Objectives - Describe the workup and staging of a patient with malignant pleural mesothelioma - List the subtypes of malignant pleural mesothelioma, characteristics of resectable disease, and patient factors which impact surgical candidacy  - Describe the approach to an extrapleural pneumonectomy and pleural decortication - Analyze which surgical approach is best for various subsets of patients - Describe the adjuvant treatment for malignant pleural mesothelioma Hosts Kelly Daus MD, Adam Bograd MD, Peter White MD, Brian Louie MD Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out more recent episodes: https://app.behindtheknife.org/listen

Reference: Marx et al. Simple Aspiration versus Drainage for Complete Pneumothorax: A Randomized Noninferiority Trial. Am J Respir Crit Care Med. 2023 Date: March 22, 2024 Guest Skeptic: Dr. Richard Malthaner holds the prestigious position of Chair/Head of the Division of Thoracic Surgery and serves as the Director of the Thoracic Robotic Program at Western […] The post SGEM#433: Breathe – Simple Aspiration vs. Drainage for Complete Pneumothorax first appeared on The Skeptics Guide to Emergency Medicine.

There are numerous causes for shortness of breath, but some require referral to a thoracic surgeon. Blair Marshall, MD, a thoracic surgeon at SMH, discusses what patients come to see her, and what their treatment options are.You can also watch the video recording on our Vimeo channel here.For more health tips & news you can use from experts you trust, sign up for Sarasota Memorial's monthly digital newsletter, Healthe-Matters.

Joining us is Dr. Brian Arnold, a thoracic surgeon at Albany Medical Center. Ray Graf hosts.

In this episode our team reviews the two groundbreaking RCTs which challenged the long-held dogma that a lobectomy is the only acceptable oncologic procedure for NSCLC. Listen as we compare and contrast the North American CALGB trial and Japanese JCOG trial which were both designed to investigate survival and recurrence outcomes by randomizing stage 1A patients to lobectomy versus a sublobar resection. Learning Objectives: -Compare and contrast the patient characteristics of the CALGB and JCOG trials -Understand the methodology each trial and be able to explain their nuanced differences -Analyze the results of the CALGB and JCOG trials and how they apply to patients today Hosts: Kelly Daus MD, Peter White MD, Eric Vallieres, MD and Brian Louie MD Referenced Material https://pubmed.ncbi.nlm.nih.gov/36780674/ Altorki N, et al. Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer. N Engl J Med. 2023 Feb 9;388(6):489-498. doi: 10.1056/NEJMoa2212083. PMID: 36780674; PMCID: PMC10036605. https://pubmed.ncbi.nlm.nih.gov/35461558/' Saji H, et al. West Japan Oncology Group and Japan Clinical Oncology Group. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial. Lancet. 2022 Apr 23;399(10335):1607-1617. doi: 10.1016/S0140-6736(21)02333-3. PMID: 35461558. https://pubmed.ncbi.nlm.nih.gov/37473998/ Altorki N, et al. Lobectomy, segmentectomy, or wedge resection for peripheral clinical T1aN0 non-small cell lung cancer: A post hoc analysis of CALGB 140503 (Alliance). J Thorac Cardiovasc Surg. 2023 Jul 18:S0022-5223(23)00612-8. doi: 10.1016/j.jtcvs.2023.07.008. Epub ahead of print. PMID: 37473998. Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our other Cardiothoracic episodes: https://behindtheknife.org/podcast-category/cardiothoracic/

The Accelerators (Drs. Matt Spraker and Simul Parikh) host the lung cancer legend, Brendon Stiles, MD. He is a Professor of Oncology, Medicine, and Thoracic Surgery at Montfiore and Albert Einstein College of Medicine.We discuss all things lung cancer: early stage, locally advanced, staging, quality, and more.The episode is capped with Simul's Lighting Round. Good luck Brendon!We hope you enjoy this #MedEd instant classic!Here are (almost?) all the studies and materials we mentioned during the show:Brendon's "Old Slide" on patient selection and operabilityLobar or Sublobar Resection for Peripheral Stage IA Non–Small-Cell Lung Cancer (CALGB 140503)Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer (I-SABR)Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials (STARS-ROSEL)Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non–Small Cell Lung Cancer (MISSILE)Stereotactic ABlative Radiotherapy Before Resection to AvoId Delay for Early-Stage LunG Cancer or OligomEts During the COVID-19 Pandemic (SABR-BRIDGE)Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non–Small-Cell Lung CancerPhase II Study of Accelerated High-Dose Radiation Therapy with Concurrent Chemotherapy for Patients With Limited Small-Cell Lung Cancer (RTOG 0239)Randomized Phase II Study of Preoperative Chemoradiotherapy ± Panitumumab Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIIa, N2+) Non-Small Cell Lung Cancer (RTOG 0839)Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer (CheckMate 816)Pacific-2 Press Release, AstraZenecaStudy of Durvalumab Given With Chemoradiation Therapy in Patients With Unresectable Non-small Cell Lung Cancer (MDT-BRIDGE, in progress)Society of Thoracic Surgeons quality initiativesThe Accelerators Podcast is a production of Photon Media, a division of Cold Light Legacy Company.If you'd like to support our efforts, please visit the Cold Light Legacy Company to learn more.

Welcome to “Live Well and Thrive,” a podcast recognizing the hard work, dedication, and diversity of our team at Kaiser Permanente Northern California. Today our topic is health disparities among certain communities we serve at KP. We will be discussing our Asian, Latin American, and African American communities in particular. Our purpose today is not to lump these communities together - far from it - but rather to address each community through the eyes of a seasoned provider to assemble insights into how we can better serve each community in different ways, meeting them where they are. Guests: Doctors Jeffrey Velotta, Thoracic Surgery, KP Oakland Medical Center; Brandy Williams, KP Woodland Hills Medical Center; and Sergio Gonzalez, Family Medicine, KP San Jose Medical Center to our podcast for this important discussion.As always, I invite you to share what's on your mind, ask a question or suggest a topic or guest. Send it to LiveWell&Thrive@kp.org. And whether you're listening on your commute or during a down moment, keep those comments coming.Additional resources:The Joint Commission on Health Care Equity (https://www.jointcommission.org/our-priorities/health-care-equity/): Advancing health care equity. Belong@KP (https://equityinclusionanddiversity.kaiserpermanente.org/knowledge/belong-kp/): Resources to help you on your journey to foster inclusion and social justice in everything we do. Health Equity Portal (https://sp-cloud.kp.org/sites/KPHealthEquityPortal): A repository of internal and external resources to advance equitable care.https://www.ktvu.com/video/1226412 https://www.ajmc.com/view/digging-into-the-increasing-lung-cancer-rate-for-female-asian-never-smokers-dr-jeffrey-velotta Hosted on Acast. See acast.com/privacy for more information.

In this engaging episode of "A Life of Flow," we explore the world of vascular surgery through a unique lens: the dynamic between Dr. Vanessa Rubio and her father Dr. Gustavo Rubio. In this fully Spanish episode, we uncover their remarkable journey in medicine, how they've transformed their home into a hub of medical innovation, and their shared dedication to vascular surgery. The episode provides insight into the challenges and rewards of this medical specialty while discussing the latest trends and innovations in the field. Join us for a conversation that underlines the significance of vascular medicine and the special familial connection that drives their passion for it. Follow Life of Flow on Instagram Follow Life of Flow on Twitter Follow Dr. Miguel Montero-Baker on Twitter About Dr. Vanessa Rubio:Dr. Vanessa Rubio, a Medical Surgeon, graduated from the Universidad Autónoma de Guadalajara in 2003. She completed her medical studies with an impressive academic record and pursued diverse international experiences, including an internship in Barcelona and social service in Jalisco. Dr. Rubio specialized in General Surgery at Hospital Valentín Gómez Farías and Angiology and Vascular Surgery at Hospital Civil Fray Antonio Alcalde, both associated with the University of Guadalajara. Her extensive academic contributions include presentations and publications, and she is a member of renowned medical associations. Her dedication to advancing vascular surgery and her commitment to patient care have established her as a respected figure in the medical community.About Dr. Gustavo Rubio:Dr. Gustavo Rubio is a highly accomplished Medical Surgeon with a rich medical career. He obtained his professional degree from the Universidad Nacional Autónoma de México in 1979 and has since held various key positions. Dr. Rubio completed his residencies in General and Cardiovascular Surgery, becoming certified in both fields. He holds specializations in Thoracic Surgery, specifically Cardiac Surgery, and Angiology and Vascular Surgery. Over the years, he has actively pursued academic growth, including international fellowships and specialized training in Endovascular Surgery and Flebology. He is a distinguished member of multiple medical associations and has received recognition for his contributions, such as the "Pioneers in Performance" award in 2013. Dr. Rubio's dedication to the field and commitment to medical excellence make him a respected figure in the world of cardiovascular and vascular surgery.

This edition of Cancer Registry World features Daniel Boffa, MD, Professor of Surgery and Chief of the Division of Thoracic Surgery at the Yale University School of Medicine. In addition to his outstanding academic surgery career, Dr. Boffa is also a leader in the development of quality benchmarks for the Commission on Cancer and the American College of Surgeons Cancer Programs. Please enjoy listening and learning!

In this two-part episode our team debates management of complex pleural effusions and empyema. Our surgical team is joined by Dr. Jed Gorden, an interventional pulmonologist, as we explore the nuances of deciding on fibrinolytic therapy (part 1) versus surgical management (part 2). Part 1: https://behindtheknife.org/podcast/clinical-challenges-in-thoracic-surgery-complex-pleural-effusions-empyema-part-1-of-2/ Learning Objectives: -Discuss the pros and cons of small bore versus large bore chest tubes for complex pleural effusions  -Review the evidence for fibrinolytic therapy for management of complex pleural effusions -Describe the surgical management of a complex pleural effusion including VATS, open thoracotomy, empyema tube, Eloesser flap, and Clagett window -Create a framework for shared-decision making with patients regarding management of a complex pleural effusion Hosts: Kelly Daus MD, Peter White MD, Jed Gorden, MD and Brian Louie MD Referenced Material https://pubmed.ncbi.nlm.nih.gov/15745977/ Maskell NA, et al. First Multicenter Intrapleural Sepsis Trial (MIST1) Group. U.K. Controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med. 2005 Mar 3;352(9):865-74. doi: 10.1056/NEJMoa042473. Erratum in: N Engl J Med. 2005 May 19;352(20):2146. PMID: 15745977. https://pubmed.ncbi.nlm.nih.gov/21830966/ Rahman NM, et al. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med. 2011 Aug 11;365(6):518-26. doi: 10.1056/NEJMoa1012740. PMID: 21830966. https://pubmed.ncbi.nlm.nih.gov/35830586/ Wilshire CL, et al. Comparing Initial Surgery versus Fibrinolytics for Pleural Space Infections: A Retrospective Multicenter Cohort Study. Ann Am Thorac Soc. 2022 Nov;19(11):1827-1833. doi: 10.1513/AnnalsATS.202108-964OC. PMID: 35830586. https://pubmed.ncbi.nlm.nih.gov/37043201/ Wilshire CL, et al. Effect of Intrapleural Fibrinolytic Therapy vs Surgery for Complicated Pleural Infections: A Randomized Clinical Trial. JAMA Netw Open. 2023 Apr 3;6(4):e237799. doi: 10.1001/jamanetworkopen.2023.7799. PMID: 37043201; PMCID: PMC10098968. Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out more thoracic surgery episodes here: https://behindtheknife.org/podcast-category/cardiothoracic/

In this two-part episode our team debates management of complex pleural effusions and empyema. Our surgical team is joined by Dr. Jed Gorden, an interventional pulmonologist, as we explore the nuances of deciding on fibrinolytic therapy (part 1) versus surgical management (part 2). Learning Objectives: -Discuss the pros and cons of small bore versus large bore chest tubes for complex pleural effusions  -Review the evidence for fibrinolytic therapy for management of complex pleural effusions -Describe the surgical management of a complex pleural effusion including VATS, open thoracotomy, empyema tube, Eloesser flap, and Clagett window -Create a framework for shared-decision making with patients regarding management of a complex pleural effusion Hosts: Kelly Daus MD, Peter White MD, Jed Gorden, MD and Brian Louie MD Referenced Material https://pubmed.ncbi.nlm.nih.gov/15745977/ Maskell NA, et al. First Multicenter Intrapleural Sepsis Trial (MIST1) Group. U.K. Controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med. 2005 Mar 3;352(9):865-74. doi: 10.1056/NEJMoa042473. Erratum in: N Engl J Med. 2005 May 19;352(20):2146. PMID: 15745977. https://pubmed.ncbi.nlm.nih.gov/21830966/ Rahman NM, et al. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med. 2011 Aug 11;365(6):518-26. doi: 10.1056/NEJMoa1012740. PMID: 21830966. https://pubmed.ncbi.nlm.nih.gov/35830586/ Wilshire CL, et al. Comparing Initial Surgery versus Fibrinolytics for Pleural Space Infections: A Retrospective Multicenter Cohort Study. Ann Am Thorac Soc. 2022 Nov;19(11):1827-1833. doi: 10.1513/AnnalsATS.202108-964OC. PMID: 35830586. https://pubmed.ncbi.nlm.nih.gov/37043201/ Wilshire CL, et al. Effect of Intrapleural Fibrinolytic Therapy vs Surgery for Complicated Pleural Infections: A Randomized Clinical Trial. JAMA Netw Open. 2023 Apr 3;6(4):e237799. doi: 10.1001/jamanetworkopen.2023.7799. PMID: 37043201; PMCID: PMC10098968. Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out more thoracic surgery episodes here: https://behindtheknife.org/podcast-category/cardiothoracic/

Today, I am blessed to have here with me Dr. Steven Gundry. He is a cum laude graduate of Yale University with special honors in Human Biological and Social Evolution. After graduating Alpha Omega Alpha from the Medical College of Georgia School of Medicine, Dr. Steven Gundry completed residencies in General Surgery and Thoracic Surgery at the University of Michigan and served as a Clinical Associate at the National Institutes of Health for years. There, he invented devices that reverse the cell death seen in acute heart attacks; variations of these devices subsequently became the Gundry™ Retrograde Cardioplegia Cannula. It has become the world's most widely used device of its kind to protect the heart from damage during open-heart surgery.  In 2002, Dr. Gundry met someone who would change the trajectory of his career… and life. He crossed paths with an "inoperable" patient named “Big Ed”. Using a combination of dietary changes and nutraceutical supplements — Big Ed lost weight and cleared most of his arterial blockages. An obese, chronic "diet" failure himself, Dr. Gundry adapted his Yale University thesis to design a diet for himself based on evolutionary genetic coding. On this diet, he lost weight — to the tune of 70 pounds — and reversed his own ailments, such as migraines, pre-diabetic status, and arthritis. He stopped eating sugar, grains, peanuts and cashews, nightshades and other lectin-heavy foods. Having experienced weight loss and the results of eating a lectin-free and gluten-free diet himself, and inspired by growing research involving the NIH's Human Microbiome Project, his commitment to better health and longevity through a better diet solidified. His work creating nutraceutical products and supplements advanced. He is now the leading expert on the lectin-free lifestyle as the key to reversing disease and healing a leaky gut. Dr. Steven Gundry freely shares his research on how to maintain a healthy microbiome and live a long, vital life via his best-selling books, YouTube channel, Gundry MD blogs, and weekly health podcast, The Dr. Gundry Podcast. In this episode, Dr. Gundry defines ketosis and explains the direct benefit that ketones have on the brain. Plus, Dr. Gundry dives deep into the mitochondria and why they have to uncouple to survive. You'll find out what the “mito club” is and why calorie restriction is a non-starter, and it simply does not work. Tune in as we chat all about MCT oil, melatonin, and the benefits of sheep and goat dairy.  Order Keto Flex: http://www.ketoflexbook.com JOIN MY 90 DAY HEAVY METALS DETOX PROGRAM (9 SPOTS LEFT): HTTP://WWW.KETOKAMPDETOX.COM  -------------------------------------------------------- / / E P I S O D E   S P ON S O R S  Biotiquest Sugar Shift product. Regulate glucose, reduce cravings, achieve deeper ketosis, and remove glyphaste.  https://biotiquest.com/products/sugar-shift Use the coupon code KAMP10 for 10% off their products.  Bioptimizers Masszymes for better digestion on keto and carnivore. Get your FREE bottle of Masszymes right now by heading to http://www.masszymes.com/ketofree and use coupon code ketokamp10 .  Text me the words "Podcast" +1 (786) 364-5002 to be added to my contacts list.  [00:50] Dr. Gundry Gives His Definition of Ketosis  Generating ketone bodies is done by free fatty acids entering the liver from circulation.  The liver can convert free fatty acids into ketone bodies. Ketone bodies are short-chain fats that are water-soluble.  Ketones have a distinct benefit in getting to the brain, which free fatty acids can't because they're too big to get through the blood-brain barrier. Ketosis should happen every night after about eight hours of not eating if you are metabolically flexible.  50% of ordinary people are not metabolically flexible.  [03:50] Uncoupling To Survive: How The Mitochondria Release Pressure  Dr. Gundry recommends reading Uncoupling To Survive: https://pubmed.ncbi.nlm.nih.gov/11053672/ When you're starving to death, mitochondria have to save themselves at all costs.  If mitochondria die, then it's all over.  Making energy is hard work; it's very damaging to mitochondria.  Mitochondria have to have ways of protecting themselves, and one of the ways they protect themselves is to release pressure.  There are five pressure release valves for the mitochondria.  We couple oxygen and protons to make ATP. If we uncouple the burning of oxygen from making ATP, that's how we release pressure.  [21:05] The Reason, Most People, Cannot Get Into Ketosis Right Away  Most people can not get into ketosis by following a high-fat diet because they lack metabolic flexibility.  Many people are insulin resistant. Their cells no longer listen to insulin, so insulin keeps rising and rising.  It can take three to four weeks to liberate fat from fat cells on a ketogenic diet because insulin levels stay high for so long.  The ketogenic diet came about to treat childhood epilepsy.   If you put kids on an MCT oil-based diet, with only about 50% of their calories coming from fat, they would get the same benefit as the full-blown ketogenic diet. [32:25] The “Mito Club” - How Your Body Is Just Like A Nightclub  The mito club has one entrance, and there is only one exit.  If everything works out okay, a proton and electron will couple and exit the mito club.  However, there are a lot more electrons than there are protons.  Electrons will also couple with oxygen; it's a bad match.  The mito club needs to be cleaned up every night after closing.  [38:40] Calorie Restriction Is A Non-Starter, and It Doesn't Work  The best way to expand lifespan and healthspan is calorie restriction.  However, calorie restriction is a non-starter, and it doesn't work.  Calorie-restricted animals are profoundly hungry.  A study found that the animals with time-restricted eating lived 11% longer than the animals who ate the same amount of food but ate throughout the day.  This concept has been proven in humans as well. [47:05] The Major Health Benefit of Taking MCT Oil or Powder  30% of sheep and goat dairy is MCT.  MCTs are an excellent fat that goes directly to our liver, where they are automatically converted into ketones.  You can have insulin resistance, take MCTs, and generate ketones.  A tablespoon of MCT oil will have you generating adequate amounts of ketones to begin uncoupling mitochondria.  MCTs are easy to take; you can mix them in salad dressing.  Many females have issues with MCT oils and their stomachs, so start slow. Powered MCTs work well for women.  [53:35] You Have Melatonin All Wrong: It May Have Nothing To Do With Sleep  Pistachios actually have the highest melatonin content of any food. The Mediterranean diet gets melatonin from olive oil, red wine, and mushrooms.  Melatonin isn't there to put you to sleep. Instead, it's there to repair mitochondria.  Also, melatonin may be one of the secrets of cancer therapy.  Dr. Gundry has cancer patients on up to 100 milligrams a day of melatonin.  Check out Melatonin The Miracle Molecule: https://www.ultimatecellularreset.com/product/melatonin-the-miracle-molecule/ AND MUCH MORE! Resources from this episode:  Check out Dr. Gundry's Website: https://drgundry.com/ (use code “gundry30”) Follow Dr. Gundry Instagram: https://www.instagram.com/drstevengundry/ Facebook: https://www.facebook.com/DrStevenGundry/ Twitter: https://twitter.com/drgundry YouTube: https://www.youtube.com/channel/UCtxo0nTZjzlKJq5-vJq6s6g Unlocking the Keto Code: The Revolutionary New Science of Keto That Offers More Benefits Without Deprivation: https://www.amazon.com/gp/product/0063118386/benazadi-20 Listen to The Dr. Gundry Podcast: https://drgundry.com/the-dr-gundry-podcast/ Uncoupling to Survive: https://pubmed.ncbi.nlm.nih.gov/11053672/ Melatonin The Miracle Molecule: https://www.ultimatecellularreset.com/product/melatonin-the-miracle-molecule/ Join the Keto Kamp Academy: https://ketokampacademy.com/7-day-trial-a Watch Keto Kamp on YouTube: https://www.youtube.com/channel/UCUh_MOM621MvpW_HLtfkLyQ Order Keto Flex: http://www.ketoflexbook.com JOIN MY 90 DAY HEAVY METALS DETOX PROGRAM (9 SPOTS LEFT): HTTP://WWW.KETOKAMPDETOX.COM  -------------------------------------------------------- / / E P I S O D E   S P ON S O R S  Biotiquest Sugar Shift product. Regulate glucose, reduce cravings, achieve deeper ketosis, and remove glyphaste.  https://biotiquest.com/products/sugar-shift Use the coupon code KAMP10 for 10% off their products.  Bioptimizers Masszymes for better digestion on keto and carnivore. Get your FREE bottle of Masszymes right now by heading to http://www.masszymes.com/ketofree and use coupon code ketokamp10 .  Text me the words "Podcast" +1 (786) 364-5002 to be added to my contacts list.  *Some Links Are Affiliates* // F O L L O W ▸ instagram | @thebenazadi | http://bit.ly/2B1NXKW ▸ facebook | /thebenazadi | http://bit.ly/2BVvvW6 ▸ twitter | @thebenazadi http://bit.ly/2USE0so ▸clubhouse | @thebenazadi Disclaimer: This podcast is for information purposes only. Statements and views expressed on this podcast are not medical advice. This podcast including Ben Azadi disclaim responsibility from any possible adverse effects from the use of information contained herein. Opinions of guests are their own, and this podcast does not accept responsibility of statements made by guests. This podcast does not make any representations or warranties about guests qualifications or credibility. Individuals on this podcast may have a direct or non-direct interest in products or services referred to herein. If you think you have a medical problem, consult a licensed physician.

In this episode, our team discusses the Checkmate 577 trial, the landmark paper which approved the use of nivolumab for adjuvant treatment of stage II & III esophageal & GE junction cancer. Listen as our team reviews the study population, methods and results of this trial & discusses its clinical application as well as potential areas of future research. Learning Objectives: -Review the staging and treatment of esophageal and GEJ cancer -Discuss the population, methods, and results of the Checkmate 577 trial -Understand the mechanism of action of nivolumab and the PD1 pathway -Discuss the implications of the Checkmate 577 trial in clinical practice and areas of future research Hosts: Kelly Daus MD, Megan Lenihan MD, Peter White MD, and Brian Louie MD Referenced Material https://www.nejm.org/doi/full/10.1056/NEJMoa2032125 Kelly RJ, Ajani JA, Kuzdzal J, et al. Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer. N Engl J Med. 2021;384(13):1191-1203. doi:10.1056/NEJMoa2032125 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136921/ Han Y, Liu D, Li L. PD-1/PD-L1 pathway: current researches in cancer. Am J Cancer Res. 2020 Mar 1;10(3):727-742. PMID: 32266087; PMCID: PMC7136921. Ad referenced in episode: A team at the Brooke Army Medical Center is working to better define proficiency-based metrics for competency in commonly performed robotic general surgery procedures. If you are a general surgery resident or practicing surgeon who performs robotic assisted cholecystectomies or inguinal hernia repairs,  reach out to the PI, Robert Laverty, MD, at rblaverty@gmail.com for more information on how you could be compensated $500 per video submitted of each (up to $1000 per surgeon). Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out other thoracic surgery episodes here https://behindtheknife.org/podcast-category/cardiothoracic/